Asik Murat, Guner Akbiyik Ayten
Department of Radiology, Istanbul Medeniyet University, Istanbul, TUR.
Radiology, Prof. Dr. Suleyman Yalcin City Hospital, Istanbul, TUR.
Cureus. 2024 Feb 12;16(2):e54049. doi: 10.7759/cureus.54049. eCollection 2024 Feb.
Purpose This study aims to assess the significance of imaging techniques and needle thickness employed in transthoracic core needle biopsy for determining the cancer type and subtypes, ultimately guiding the treatment of lung cancer. Material and methods Between 2018 and 2023, a cohort of 350 patients (69.7% male, 30.3% female) underwent CT-guided lung biopsy, predominantly utilizing core biopsies. Fine needle aspiration biopsies employed 18 or 20 G Chiba needles, while core needle biopsies utilized 16 or 18-gauge coaxial system semi-automatic needles. The preferred needle and biopsy sample size were 16 G in thickness and 2 cm in length. Pre-procedure positron emission tomography-computed tomography (PET-CT) images aided in identifying the most homogenous lesion with the highest SUV max value, guiding biopsy sample extraction. Post-procedure control CT evaluated complications according to the Society of Interventional Radiology (SIR) reporting standard. Results The average age of biopsied patients was 65.48 +/- 12.32 SD (range: 18-90). Tru-cut biopsy was predominant (69.7%), utilizing a larger number of 16G needles. Pathological diagnoses were mostly malignant (76.6%), with lesion sizes averaging 35.98 +/- 17.90 SD (range: 5-105 mm) and distances to pleura averaging 13.48 +/- 13.54 SD (range: 0-86 mm). Malignancy prevalence was higher in males (56.8%), tru-cut biopsies (72.7%), 16G needles used for tru-cut (47.7%), and PET-CT evaluation (59.1%). Complications were identified in 22% of cases, with distance to pleura significantly associated (p < 0.001). No significant differences in complication risk were observed between FNAB and tru-cut and between needle gauges (20 G-18 G and 16 G) (p: 0.734, p: 0.638, respectively). Conclusion The study underscores the paramount importance of biopsy sample size in diagnosing lung cancers and determining targeted therapy. Optimal biopsy localization, informed by pre-procedure imaging techniques, is crucial. Hence, the recommendation is to utilize the thickest needles and largest samples for lung biopsies.
目的 本研究旨在评估经胸芯针活检中使用的成像技术和针的粗细对于确定癌症类型和亚型的重要性,最终指导肺癌的治疗。
材料与方法 2018年至2023年期间,350例患者(男性占69.7%,女性占30.3%)接受了CT引导下的肺活检,主要采用芯针活检。细针穿刺活检使用18或20G千叶针,而芯针活检使用16或18G同轴系统半自动针。首选的针和活检样本大小为厚度16G、长度2cm。术前正电子发射断层扫描-计算机断层扫描(PET-CT)图像有助于识别具有最高SUV最大值的最均匀病变,指导活检样本提取。术后对照CT根据介入放射学会(SIR)报告标准评估并发症。
结果 接受活检患者的平均年龄为65.48±12.32标准差(范围:18 - 90岁)。切割针活检占主导(69.7%),使用了更多的16G针。病理诊断大多为恶性(76.6%),病变大小平均为35.98±17.90标准差(范围:5 - 105mm),距胸膜的距离平均为13.48±13.54标准差(范围:0 - 86mm)。男性(56.8%)、切割针活检(72.7%)、切割针使用16G针(47.7%)和PET-CT评估(59.1%)的恶性患病率较高。22%的病例发现有并发症,距胸膜的距离与之显著相关(p < 0.001)。在细针穿刺活检与切割针活检之间以及针的粗细(20G - 18G和16G)之间未观察到并发症风险的显著差异(p值分别为0.734和0.638)。
结论 该研究强调了活检样本大小在诊断肺癌和确定靶向治疗中的至关重要性。术前成像技术指导下的最佳活检定位至关重要。因此,建议在肺活检中使用最粗的针和最大的样本。